elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26991991-6CFE9EA6-F7F2-405E-A4ED-35A7C6F6A1A6
Q26991991-6CFE9EA6-F7F2-405E-A4ED-35A7C6F6A1A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26991991-6CFE9EA6-F7F2-405E-A4ED-35A7C6F6A1A6
Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes
P2860
Q26991991-6CFE9EA6-F7F2-405E-A4ED-35A7C6F6A1A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26991991-6CFE9EA6-F7F2-405E-A4ED-35A7C6F6A1A6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e19807ec57af128d8dd62a29f594e370bf919adc
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer